A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

DUI

D009257 MeSH Browser

CUI

M0014423

CAS

2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester

Previous indexing

Diethylamines (1974); Naphthalenes (1971-1974); Furans (1971-1974); Propionates (1971-1974)

History note

91(75); was see under FURANS 1975-90

Public note

91; was see under FURANS 1975-90